192 related articles for article (PubMed ID: 12449394)
1. Fluorescence-based functional assay for Wnt/beta-catenin signaling activity.
Zhou L; An N; Jiang W; Haydon R; Cheng H; Zhou Q; Breyer B; Feng T; He TC
Biotechniques; 2002 Nov; 33(5):1126-8, 1130, 1132 passim. PubMed ID: 12449394
[TBL] [Abstract][Full Text] [Related]
2. Murine Frizzled-1 behaves as an antagonist of the canonical Wnt/beta-catenin signaling.
Roman-Roman S; Shi DL; Stiot V; Haÿ E; Vayssière B; Garcia T; Baron R; Rawadi G
J Biol Chem; 2004 Feb; 279(7):5725-33. PubMed ID: 14627707
[TBL] [Abstract][Full Text] [Related]
3. A transgenic Lef1/beta-catenin-dependent reporter is expressed in spatially restricted domains throughout zebrafish development.
Dorsky RI; Sheldahl LC; Moon RT
Dev Biol; 2002 Jan; 241(2):229-37. PubMed ID: 11784107
[TBL] [Abstract][Full Text] [Related]
4. The C-terminal transactivation domain of beta-catenin is necessary and sufficient for signaling by the LEF-1/beta-catenin complex in Xenopus laevis.
Vleminckx K; Kemler R; Hecht A
Mech Dev; 1999 Mar; 81(1-2):65-74. PubMed ID: 10330485
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity.
Zhou L; An N; Haydon RC; Zhou Q; Cheng H; Peng Y; Jiang W; Luu HH; Vanichakarn P; Szatkowski JP; Park JY; Breyer B; He TC
Cancer Lett; 2003 Apr; 193(2):161-70. PubMed ID: 12706873
[TBL] [Abstract][Full Text] [Related]
6. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
7. Beta-catenin/Tcf activation partially mimics the transforming activity of Wnt-1 in Rat-1 fibroblasts.
Young CS; Masckauchan TN; Kitajewski J
Differentiation; 2003 Oct; 71(8):477-85. PubMed ID: 14641328
[TBL] [Abstract][Full Text] [Related]
8. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells.
Mizushima T; Nakagawa H; Kamberov YG; Wilder EL; Klein PS; Rustgi AK
Cancer Res; 2002 Jan; 62(1):277-82. PubMed ID: 11782388
[TBL] [Abstract][Full Text] [Related]
9. Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation.
Liu BY; Kim YC; Leatherberry V; Cowin P; Alexander CM
Oncogene; 2003 Dec; 22(58):9243-53. PubMed ID: 14681683
[TBL] [Abstract][Full Text] [Related]
10. Wnt/beta-catenin signaling suppresses apoptosis in low serum medium and induces morphologic change in rodent fibroblasts.
Ueda Y; Hijikata M; Takagi S; Takada R; Takada S; Chiba T; Shimotohno K
Int J Cancer; 2002 Jun; 99(5):681-8. PubMed ID: 12115501
[TBL] [Abstract][Full Text] [Related]
11. A possible role for the WNT-1 pathway in oral carcinogenesis.
Lo Muzio L
Crit Rev Oral Biol Med; 2001; 12(2):152-65. PubMed ID: 11345525
[TBL] [Abstract][Full Text] [Related]
12. A comparative evaluation of beta-catenin and plakoglobin signaling activity.
Williams BO; Barish GD; Klymkowsky MW; Varmus HE
Oncogene; 2000 Nov; 19(50):5720-8. PubMed ID: 11126358
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin is critical for dendritic morphogenesis.
Yu X; Malenka RC
Nat Neurosci; 2003 Nov; 6(11):1169-77. PubMed ID: 14528308
[TBL] [Abstract][Full Text] [Related]
14. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
[TBL] [Abstract][Full Text] [Related]
16. Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription.
Staal FJ; Meeldijk J; Moerer P; Jay P; van de Weerdt BC; Vainio S; Nolan GP; Clevers H
Eur J Immunol; 2001 Jan; 31(1):285-93. PubMed ID: 11265645
[TBL] [Abstract][Full Text] [Related]
17. WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells.
Papkoff J; Aikawa M
Biochem Biophys Res Commun; 1998 Jun; 247(3):851-8. PubMed ID: 9647782
[TBL] [Abstract][Full Text] [Related]
18. Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1.
Aoki M; Hecht A; Kruse U; Kemler R; Vogt PK
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):139-44. PubMed ID: 9874785
[TBL] [Abstract][Full Text] [Related]
19. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.
Porfiri E; Rubinfeld B; Albert I; Hovanes K; Waterman M; Polakis P
Oncogene; 1997 Dec; 15(23):2833-9. PubMed ID: 9419974
[TBL] [Abstract][Full Text] [Related]
20. Identification of a mouse homolog of the human BTEB2 transcription factor as a beta-catenin-independent Wnt-1-responsive gene.
Ziemer LT; Pennica D; Levine AJ
Mol Cell Biol; 2001 Jan; 21(2):562-74. PubMed ID: 11134343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
